Literature DB >> 16554730

Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.

Paolo Cossu-Rocca1, John N Eble, Brett Delahunt, Shaobo Zhang, Guido Martignoni, Matteo Brunelli, Liang Cheng.   

Abstract

Mucinous tubular and spindle cell carcinoma of the kidney is an uncommon, distinctive neoplasm characterized by the proliferation of cuboidal and spindle cells arranged in tubular or sheet-like arrays, typically with a mucinous or myxoid background. The most important differential diagnostic consideration of mucinous tubular and spindle cell carcinoma is papillary renal cell carcinoma, type 1, with sarcomatoid transformation. The aim of our study is to investigate the pattern of possible gains or losses of chromosomes 7, 17 and Y in 10 mucinous tubular and spindle cell carcinomas with interphase fluorescence in situ hybridization (FISH). Four-micron sections were obtained from paraffin blocks representative of the tumors and including adjacent non-neoplastic renal parenchyma from 10 patients. The patients' ages ranged from 20 to 80 years (mean: 62 years); eight were female, while two were male. FISH analysis was performed with centromeric probes for chromosomes 7, 17 and Y. One hundred fifty to 200 nuclei from each case were scored for hybridization signals and non-neoplastic parenchyma served as control tissue. We found that renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are typical of papillary renal cell carcinoma. FISH analysis with centromeric probes for these chromosomes is potentially helpful in differentiating mucinous tubular and spindle cell carcinomas from papillary renal cell carcinomas.

Entities:  

Mesh:

Year:  2006        PMID: 16554730     DOI: 10.1038/modpathol.3800565

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  21 in total

Review 1.  Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.

Authors:  Simon Chowdhury; Marc R Matrana; Christopher Tsang; Bradley Atkinson; Toni K Choueiri; Nizar M Tannir
Journal:  Hematol Oncol Clin North Am       Date:  2011-08       Impact factor: 3.722

2.  (18)F-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney.

Authors:  Hakan Ozturk
Journal:  Indian J Nucl Med       Date:  2015 Jan-Mar

3.  Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity.

Authors:  Sean R Williamson; Liang Cheng; John N Eble; Lawrence D True; Nilesh S Gupta; Mingsheng Wang; Shaobo Zhang; David J Grignon
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

Review 4.  Classical pathology versus molecular pathology in renal cell carcinoma.

Authors:  Peggy Soung Sullivan; JianYu Rao; Liang Cheng; Richard J Cote
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

5.  VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.

Authors:  Lisha Wang; Yuping Zhang; Ying-Bei Chen; Stephanie L Skala; Hikmat A Al-Ahmadie; Xiaoming Wang; Xuhong Cao; Brendan A Veeneman; Jin Chen; Marcin Cieślik; Yuanyuan Qiao; Fengyun Su; Pankaj Vats; Javed Siddiqui; Hong Xiao; Evita T Sadimin; Jonathan I Epstein; Ming Zhou; Ankur R Sangoi; Kiril Trpkov; Adeboye O Osunkoya; Giovanna A Giannico; Jesse K McKenney; Pedram Argani; Satish K Tickoo; Victor E Reuter; Arul M Chinnaiyan; Saravana M Dhanasekaran; Rohit Mehra
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

6.  High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment.

Authors:  Eril J Kouba; John N Eble; Novae Simper; David J Grignon; Mingsheng Wang; Shaobo Zhang; Lisha Wang; Guido Martignoni; Sean R Williamson; Matteo Brunelli; Claudio Luchini; Anna Calió; Liang Cheng
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

7.  Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation.

Authors:  Rochelle A Simon; P Anthony di Sant'agnese; Ganesh S Palapattu; Eric A Singer; Grace D Candelario; Jiaoti Huang; Jorge L Yao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 8.  Renal cell carcinoma: Evolving and emerging subtypes.

Authors:  Suzanne M Crumley; Mukul Divatia; Luan Truong; Steven Shen; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2013-12-16       Impact factor: 1.337

Review 9.  The changing face of renal cell carcinoma pathology.

Authors:  Hakan Aydin; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

10.  Renal cell carcinoma in tuberous sclerosis complex.

Authors:  Ping Yang; Kristine M Cornejo; Peter M Sadow; Liang Cheng; Mingsheng Wang; Yu Xiao; Zhong Jiang; Esther Oliva; Sergiusz Jozwiak; Robert L Nussbaum; Adam S Feldman; Elahna Paul; Elizabeth A Thiele; Jane J Yu; Elizabeth P Henske; David J Kwiatkowski; Robert H Young; Chin-Lee Wu
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.